1,3-dipropyl-8-(4-sulfophenyl)xanthine has been researched along with Seizures in 1 studies
1,3-dipropyl-8-(4-sulfophenyl)xanthine: adenosine receptor antagonist
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The role of adenosine systems in the initiation and termination of seizures was examined using a unique marker for limbic seizures--maximal dentate activation (MDA)." | 3.68 | A1 adenosinergic modulation alters the duration of maximal dentate activation. ( Lothman, EW; Stringer, JL, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stringer, JL | 1 |
| Lothman, EW | 1 |
1 other study available for 1,3-dipropyl-8-(4-sulfophenyl)xanthine and Seizures
| Article | Year |
|---|---|
A1 adenosinergic modulation alters the duration of maximal dentate activation.
Topics: 2-Chloroadenosine; Adenosine; Animals; Electric Stimulation; Hippocampus; Limbic System; Male; Rats; | 1990 |